Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease.
暂无分享,去创建一个
P. Tiberghien | J. Stéphan | E. Holler | P. Hervé | J. Wijdenes | P. Bordigoni | E. Plouvier | E. Racadot | M. Flesch | H. Bourdeau